We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

    Background

    While a neoadjuvant chemotherapy regimen using docetaxel, cisplatin, and 5-fluorouracil (NAC-DCF) is considered the standard treatment for...

    Takaomi Hagi, Osamu Shiraishi, ... Takushi Yasuda in Annals of Surgical Oncology
    Article 25 April 2024
  2. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma

    Targeted therapy attempts are needed to enhance esophageal squamous cell carcinoma (ESCC) patients’ overall survival and satisfaction of life....

    **nyu He, Yubing Zhou, ... Kangdong Liu in Oncogene
    Article 25 February 2023
  3. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma

    Radioresistance and immunosuppression remain the major obstacles in the anti-cancer treatments. This work studies the functions of sialic acid...

    Fen Zhao, Hui Tian, ... Lei Fu in Cancer Immunology, Immunotherapy
    Article Open access 23 January 2023
  4. Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram

    Background

    Malignant esophageal fistula (MEF), which occurs in 5% to 15% of esophageal cancer (EC) patients, has a poor prognosis. Accurate...

    Chao Zhu, Wenju Sun, ... Xuezhen Ma in European Journal of Medical Research
    Article Open access 04 April 2024
  5. YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma

    Purpose

    Targeting angiogenesis is an attractive strategy for the effective treatment of cancer. This study aimed to investigate the anti-cancer...

    Xue-Wei Wang, Rong Zhao, ... **ao-**a Wang in Journal of Cancer Research and Clinical Oncology
    Article 31 March 2023
  6. Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study

    Background

    Neoadjuvant chemoradiotherapy (NCRT) has shown promise in improving the prognosis of individuals with locally advanced esophageal squamous...

    **gqiu Li, **aoding Zhou, ... Qifeng Wang in Annals of Surgical Oncology
    Article 27 January 2024
  7. Huge esophageal gastrointestinal stromal tumor successfully resected under mediastino-laparoscopic transhiatal esophagectomy: a case report

    Background

    Esophageal gastrointestinal stromal tumors (E-GISTs) are often diagnosed early due to complaints such as dysphagia and are rarely found to...

    Keisuke Mishima, Takeshi Matsutani, ... Hiroshi Yoshida in Surgical Case Reports
    Article Open access 06 June 2022
  8. Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review

    Introduction

    The tumor microenvironment (TME) plays a crucial role in therapy response and modulation of immunologic surveillance. Adjuvant...

    H. H. Wang, E. N. Steffens, ... J. T. M. Plukker in Annals of Surgical Oncology
    Article Open access 30 September 2023
  9. Prediction of Esophageal Stricture after Endoscopic Submucosal Dissection in Patients with Early Esophageal Cancer

    Background

    Endoscopic submucosal dissection (ESD) treatment of early esophageal cancer is effective and safe. It is currently the first-line treatment...

    Bo Zhou, Zhe Zhao, ... Chun-Hui Lan in Journal of Gastrointestinal Surgery
    Article 11 October 2022
  10. Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma

    Purpose

    Esophageal squamous cell carcinoma (ESCC) remains one of the most common causes of cancer death due to the lack of effective therapeutic...

    Houxiang Jiang, Shaoxiang Wang, ... **aoshi Ma in Discover Oncology
    Article Open access 09 May 2023
  11. Esophageal cancer in an adult with congenital esophageal stenosis: a case report

    Background

    Congenital esophageal stenosis (CES) is a rare condition. We encountered a case of esophageal cancer that developed in an adult with...

    Yushi Fujiwara, Hidehiko Kitagami, ... Yasunori Nishida in Surgical Case Reports
    Article Open access 12 March 2024
  12. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease

    Purpose

    Esophageal adenocarcinoma (EAC) remains a challenging and lethal cancer entity. A promising target for new therapeutic approaches, as...

    Alyne CondurĂº dos Santos Cunha, Adrian Georg Simon, ... Alexander Quaas in Journal of Cancer Research and Clinical Oncology
    Article Open access 24 February 2023
  13. How to update esophageal masses imaging using literature review (MRI and CT features)

    Abstract

    MRI offers new opportunities for detailed visualization of the different layers of the esophageal wall, as well as early detection and...

    **rong Qu, Zhaoqi Wang, ... Ihab R. Kamel in Insights into Imaging
    Article Open access 06 July 2024
  14. Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances

    Background

    Esophageal squamous cell carcinoma (ESCC) is one of the most common tumors in the gastrointestinal tract, and China has a high incidence...

    **ao Mou, Zhenglin Peng, ... **ngwang Sun in Journal of Gastrointestinal Cancer
    Article 04 November 2023
  15. Predictive factors for esophageal stenosis in patients receiving prophylactic steroid therapy after endoscopic submucosal dissection for esophageal squamous cell carcinoma

    Background

    Methods to prevent esophageal stenosis (ES) after endoscopic submucosal dissection (ESD) for superficial esophageal squamous cell carcinoma...

    Junichi Mizuno, Yuji Urabe, ... Shinji Tanaka in BMC Gastroenterology
    Article Open access 20 January 2024
  16. Safety and efficacy of endoscopic submucosal dissection for superficial esophageal cancer with esophageal varices

    Background

    Heavy drinking is associated with esophageal cancer and esophageal varices. However, there are limited reports of endoscopic resection for...

    Tatsuya Nakai, Tetsuya Yoshizaki, ... Yuzo Kodama in Esophagus
    Article 15 April 2023
  17. The Impact of Pretreatment Esophageal Stenosis on Survival of Esophageal Cancer Patients

    Background

    Little is known about the survival impacts of pretreatment cancerous stenosis on patients with esophageal carcinoma (EC).

    Methods ...
    Kotaro Sugawara, Takashi Fukuda, ... Yoshiyuki Kawashima in Annals of Surgical Oncology
    Article 26 December 2022
  18. Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy

    Background

    Esophageal fistula is one of the most serious complications of chemotherapy or chemoradiotherapy (CRT) for advanced esophageal cancer. This...

    Yan-Jie Shi, Chang Liu, ... Ying-Shi Sun in Cancer Imaging
    Article Open access 04 November 2022
  19. Thoracoscopy-Assisted Esophagectomy for Esophageal Leiomyomatosis

    Introduction

    Diffuse esophageal leiomyomatosis is a rare esophageal tumor characterized by circumferential thickening of smooth muscle layers of the...

    Lokesh Agarwal, Vaibhav Kumar Varshney, ... Sudeep Khera in Journal of Gastrointestinal Cancer
    Article 07 October 2023
Did you find what you were looking for? Share feedback.